⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTVT News
vTv Therapeutics Inc. Class A Common Stock
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VTVT
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VTVT
Form 8-K
sec.gov
VTVT
Oryn Therapeutics Advances Next Phase of Orynotide™ Macrocyclic Peptide Platform Development with Expanded Leadership Team and Board Anchored by Accomplished Life Sciences Industry Veterans, Company Builders and Drug Developers
globenewswire.com
VTVT
Apnimed Appoints Experienced Pharmaceutical Executive Kevin R. Lind as Chief Executive Officer to Implement Next Phase of Growth Strategy
prnewswire.com
LBRX
VTVT
VEEV
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VTVT
Form 8-K
sec.gov
VTVT
Form 8-K
sec.gov
VTVT
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
VTVT
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VTVT